Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) EPS (Basic) (2010 - 2026)

Geron's (GERN) quarterly EPS (Basic) came in at -$0.02 in Q2 2026, down 1.6% year-over-year from -$0.03 in Q2 2025, and down 364.88% quarter-over-quarter from -$0.01 in Q1 2026.

Analysis

Geron (GERN) EPS (Basic) (2010 - 2026) Analysis & Trends

Geron has disclosed EPS (Basic) across 17 years of filings, most recently posting -$0.02 for Q2 2026.

  • In Q2 2026, EPS (Basic) fell 1.6% year-over-year to -$0.02; the TTM figure through Jun 2026 stood at -$0.1 (up 22.24% YoY), while the FY2025 annual figure was -$0.12, up 53.34% from the prior year.
  • EPS (Basic) came in at -$0.02 for Q2 2026 at Geron, down from -$0.01 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q1 2026 to a low of -$0.11 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$0.06, with a median of -$0.07 recorded in 2022.
  • Year-over-year, EPS (Basic) tumbled 30.8% in 2024 and jumped 81.96% in 2026.
  • Over 5 years, EPS (Basic) stood at -$0.11 in 2022, then gained by 18.76% to -$0.09 in 2023, then jumped by 59.93% to -$0.04 in 2024, then declined by 18.24% to -$0.04 in 2025, then soared by 42.39% to -$0.02 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.02 in Q2 2026, -$0.01 in Q1 2026, and -$0.04 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 4.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -8.44
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 4.34
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 12.62
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 7.70
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -1.96
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.23
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.66
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -0.40
10 Geron 914.60 Mn 613.75 Mn - -0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.02
Mar 31, 2026 -0.01
Dec 31, 2025 -0.04
Sep 30, 2025 -0.03
Jun 30, 2025 -0.02
Mar 31, 2025 -0.03
Dec 31, 2024 -0.04
Sep 30, 2024 -0.04
Jun 30, 2024 -0.10
Mar 31, 2024 -0.09
Dec 31, 2023 -0.09
Sep 30, 2023 -0.08
Jun 30, 2023 -0.09
Mar 31, 2023 -0.07
Dec 31, 2022 -0.11
Sep 30, 2022 -0.10
Jun 30, 2022 -0.07
Mar 31, 2022 -0.09
Dec 31, 2021 -0.10
Sep 30, 2021 -0.08